Faculty

Anna Wald

Professor, Epidemiology
Professor, Medicine - Allergy and Infectious Dis.
Professor, Laboratory Medicine and Pathology

206-520-4340

Education

MD Medicine, Mt Sinai School of Medicine, 1985
MPH Epidemiology, University of Washington, 1994
BA Comparative Religion, Wesleyan University, 1979

Contact

206-520-4340

University of Washington
Box 359928
325 9th Avenue
Seattle, WA 98104

Research Areas

Research Interests

Dr. Wald's current research centers on the epidemiology and natural history of chronic viral infections in immunocompetent and immunocompromised hosts. She is also working on clinical trials of antiviral therapeutics and prophylactic and therapeutic vaccines for viral pathogens. Other ongoing studies address the interaction between sexually transmitted infections and microbiome.

Recent Publications (PubMed)

Treponema pallidum Periplasmic and Membrane Proteins Are Recognized by Circulating and Skin CD4+ T Cells.
(2024 Jun 27)
J Infect Dis
Reid TB, Godornes C, Campbell VL, Laing KJ, Tantalo LC, Gomez A, Pholsena TN, Lieberman NAP, Krause TM, Cegielski VI, Culver LA, Nguyen N, Tong DQ, Hawley KL, Greninger AL, Giacani L, Cameron CE, Dombrowski JC, Wald A, Koelle DM
Viral genomic variation and the severity of genital HSV-2 infection as quantified by shedding rate: a viral genome-wide association study.
(2024 May 28)
J Infect Dis
Casto AM, Song H, Xie H, Selke S, Roychoudhury P, Wu MC, Wald A, Greninger AL, Johnston C
Performance characteristics of highly automated HSV-1 and HSV-2 IgG testing.
(2024 Jun 12)
J Clin Microbiol 62(6): e0026324
Crawford KHD, Selke S, Pepper G, Goecker E, Sobel A, Wald A, Johnston C, Greninger AL
Treponema pallidum periplasmic and membrane proteins are recognized by circulating and skin CD4+ T cells.
(2024 Feb 29)
bioRxiv
Reid TB, Godornes C, Campbell VL, Laing KJ, Tantalo LC, Gomez A, Pholsena TN, Lieberman NAP, Krause TM, Cegielski VI, Culver LA, Nguyen N, Tong DQ, Hawley KL, Greninger AL, Giacani L, Cameron CE, Dombrowski JC, Wald A, Koelle DM
Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Subvariant Neutralization Following a Primary Vaccine Series of NVX-CoV2373 and BNT162b2 Monovalent Booster Vaccine.
(2024 Feb)
Open Forum Infect Dis 11(2): ofad673
Babu TM, Shen X, McClelland RS, Wang Z, Selke S, Wilkens C, Hauge KA, McClurkan CL, Goecker E, Laing KJ, Koelle DM, Greninger AL, Nussenzweig MC, Montefiori DC, Corey L, Wald A
Show complete publication list